Global Acromegaly Market Insights 2029: Drivers, Challenges, and Revenue Forecast
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Acromegaly Market?
The market size for acromegaly has experienced a swift increase in the recent past. It is projected to expand from a value of $2.15 billion in 2024 to $2.56 billion by the year 2025, indicating a compound annual growth rate (CAGR) of 19.3%. Factors such as the rising prevalence of acromegaly treatment, growing cognizance of the condition, government actions, and the need for efficient therapies, are known to contribute to the growth witnessed during the past period.
Expectations are high for the acromegaly market, with predictions of rapid expansion in the coming years. With an anticipated growth rate (CAGR) of 17.8%, the market size could reach $4.93 billion by 2029. This growth is attributed to a number of reasons, including increasing investments in acromegaly treatment research and development, a rise in screening programs, an escalation in healthcare spending, and a growing demand for minimally invasive treatment alternatives. Forecasted trends for this period encompass novel therapeutic treatments for acromegaly, the cultivation of targeted therapies, a robust drug pipeline, progress in treatment alternatives, and the evolution of advanced personalized medicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp
What Market Forces Are Contributing To The Growth Of The Acromegaly Market?
The acromegaly market is anticipated to expand due to the escalating incidence of hormonal disorders such as diabetes. Hormonal illnesses, frequently referred to as endocrine disorders, stem from impaired functionality of the endocrine system, with diabetes being one of the most widespread and impactful conditions. Overproduction of certain hormones like growth hormone or cortisol can give rise to acromegaly and other endocrine diseases. Also, because of the effect of increased growth hormone on the synthesis of insulin, approximately 50% of individuals suffering from acromegaly might experience insulin resistance or type 2 diabetes mellitus. For example, data from the UK government department, Office for Health Improvement and Disparities, indicated that between March 2022 and March 2023, there was a rise of 22% and 21% in the percentage of individuals with type 1 and type 2 diabetes respectively receiving all eight suggested care processes. Concurrently, the percentage hitting target HbA1c levels climbed to 37.9%, which is a record high reported by the National Diabetes Audit (NDA). As such, the acromegaly market is being propelled by the increasing prevalence of hormonal diseases.
Which Segmentation Factors Are Critical In The Acromegaly Market Analysis?
The acromegalymarket covered in this report is segmented –
1) By Type: Ectopic Acromegaly; Acromegaly Due To Growth Hormone
2) By Diagnosis: GH And IGF-I Measurement; Growth Hormone Suppression Test; Imaging; Other Diagnosis
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Treatment: Medication; Somatostatin analogues; Dopamine Agonists; Growth Hormone Antagonist; Surgery; Radiation; Other Treatments
5) By End Users: Hospitals; Specialty Clinics; Homecare; Other End Users
Subsegments:
1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly; Non-Tumor-Induced Ectopic Acromegaly
2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess; Secondary Growth Hormone Excess
What New Opportunities Are Emerging From Trends In The Acromegaly Market?
The leading companies in the acromegaly market are striving to innovate their products and solutions, such as generic lanreotide, to improve treatment alternatives and patient results. Generic lanreotide is a non-branded version of the medicine used to treat acromegaly and specific neuroendocrine tumors, operating as a somatostatin analogue. It decreases the secretion of growth hormones, bolstering patient accessibility to effective medical interventions. For example, Teva Pharmaceutical Industries Ltd., a pharmaceutic firm based in Israel that concentrates on generic medications, introduced the first and unique generic iteration of Sandostatin LAR Depot in the U.S. in October 2024. The injectable solution, known as octreotide acetate, is used to treat acromegaly and severe diarrhoea related to the carcinoid syndrome. This advancement improves the availability of essential therapy for patients who need these treatments.
Which Organizations Are At The Forefront Of The Acromegaly Market?
Major companies operating in the acromegaly market are Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH., Amgen Inc., Allergan Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Pharma S.A., Hikma Pharmaceuticals PLC, Lupin Ltd., Recordati S.p.A., Ionis Pharmaceuticals Inc., Amryt Pharma plc, Strongbridge Biopharma PLC, Aquestive Therapeutics Inc., Peptron Inc., Crinetics Pharmaceuticals, Chiasma Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report
Which Region Is Leading Innovation In The Acromegaly Market?
North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12913&type=smp
Browse Through More Reports Similar to the Global Acromegaly Market 2025, By The Business Research Company
Generic Central Nervous System Drugs Global Market Report 2025
Nerve Repair And Regenerative Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
Central Nervous System Biomarkers Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
